Holt I J, Miller D H, Harding A E
University Department of Clinical Neurology, Institute of Neurology, London.
J Med Genet. 1989 Dec;26(12):739-43. doi: 10.1136/jmg.26.12.739.
Analysis of mitochondrial DNA from patients with Leber's hereditary optic neuropathy and their relatives showed that the previously reported mutation at base pair (bp) 11778, shown by loss of a recognition site for the restriction endonuclease SfaNI, was present in only four out of eight families. This mutation was associated with a poor prognosis for visual recovery, whereas four of five affected males without the 11778 bp mutation followed for four years or more had regained useful vision. All but one of the subjects showing the SfaNI site loss had a variable mixture of mutant and normal mitochondrial DNA in peripheral blood, and the relative proportions appeared to be correlated with the risk of developing or transmitting Leber's hereditary optic neuropathy.
对患有Leber遗传性视神经病变的患者及其亲属的线粒体DNA分析表明,先前报道的位于碱基对(bp)11778处的突变(通过限制性内切酶SfaNI识别位点的缺失显示)仅在八个家族中的四个家族中存在。这种突变与视力恢复的预后不良相关,而在随访四年或更长时间的五名无11778 bp突变的受影响男性中,有四名恢复了有用的视力。除一名外,所有显示SfaNI位点缺失的受试者外周血中突变型和正常线粒体DNA存在不同程度的混合,且相对比例似乎与患Leber遗传性视神经病变或传播该病的风险相关。